Election

Ted Cruz Objects to Arizona’s Electoral College Results, Senate to Debate

posted by Hannity Staff - 1.06.21

Senator Ted Cruz formally objected to Arizona’s Electoral College results Wednesday; sparking a two hour debate as Congress meets to certify the 2020 race for the White House.

“It is,” said Cruz when asked of an Arizona Congressman’s objections were signed by a Senator.

 

Watch the historic moment above.

CRUZ MISSILE: Cruz Asks Twitter to BAN CNN Over Post Promoting Same Drug That Got Trump Jr Barred

posted by Hannity Staff - 7.29.20

Senator Ted Cruz demanded Twitter ban CNN from its platform Tuesday night; pointing out the network promoted the same treatment for CoVID-19 that got Donald Trump Jr’s account frozen this week.

“Twitter, please ban CNN,” posted Cruz, citing the story.

 

 

“A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped Covid-19 patients better survive in the hospital,” posted CNN on July 3rd.

Twitter temporarily restricted Trump Jr’s account after posting a video promoting the treatment.

CRUZ MISSILE: Senator Says ‘Dems Party of the Rich, GOP Party of the Working Class’

posted by Hannity Staff - 11.30.20

Senator Ted Cruz called-out his Democratic colleagues on social media over the Thanksgiving holiday weekend; saying far-left politicians are the “party of the rich” while Republicans “are and should be the party of the working class.”

“Today’s Dems are the party of the rich. GOP is and should be the party of the working class,” posted Cruz on Twitter.

 

Cruz’ message was referencing a recent study showing Joe Biden won more than 50% of the highest income counties in the United States; up dramatically from the 1980 election.

Thank you for visiting Hannity.com. You are about to leave
Hannity.com and proceed to a site owned and operated by a third party.
Hannity.com has no control over the content of this third-party site.
Click OK to proceed.
OK
X
You may if you would no longer like to receive a newsletter.
You have been successfully unsubscribed!
Please see our Terms of Use and Privacy Notice .
If you have any questions or concerns please contact us.